Frederic Askin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

by Mark Derewicz, staff reports — February 9, 2021 . CHAPEL HILL – An experimental drug created at a subsidiary of Emory University has shown potential to both prevent and treat COVID-19, according to researchers at UNC-Chapel Hill. The drug, known as EIDD-2801, is being developed by Miami-based Ridgeback Biotherapeutics. Ridgeback is partnered with drug giant Merck in the development process. The drug was invented at Drug Innovations at Emory, a not-for-profit biotechnology company wholly owned by Emory University, according to Ridgeback. Nature, scientists at the UNC School of Medicin...

Date Time Antiviral medication works against coronavirus in lab CHAPEL HILL, N.C. – The number of new COVID-19 cases continues to rise in many parts of the world, with the highest incidence in the United States. Although several highly effective vaccines have been authorized for emergency use, it may take considerable time to reach target vaccination levels needed for herd immunity due to the logistics of vaccine manufacturing, shipping, storage, and distribution as well as public acceptance. Recently, SARS-CoV-2 variants have emerged which appear to have increased transmissibility and have...